NLRP3 and Hepatic fibrosis: In this context, genetic knockout of NLRP3 ameliorated aldosterone-induced hepatic fibrosis, while spironolactone treatment inhibited NLRP3 activation and significantly reduced liver damage in fibrosis mouse models.